“Tumour Microenvironment Modulation to Overcome Checkpoint Resistance: Where the Preclinical Rationale Holds”, TMTJ, vol. 5, no. 2, pp. 28–36, Apr. 2026, doi: 10.5281/zenodo.22649559.